A First-in-Human Study to Assess Single Doses of APNmAb005 in Healthy Participants

Clinical trial NCT05344989 · UNKNOWN

Trial details

NCT number: NCT05344989
Sponsor: APRINOIA Therapeutics, LLC
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers Tauopathies Alzheimer Disease

Start date: 2022-05-06
Primary completion: 2024-03-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.